O Kirk
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
Cozzi-Lepri A, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso M, Lundgren J, Mocroft A, Gottfredsson M, Schmid P, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, EuroSIDA Study Group. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med 2017
06.10.2017Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
06.10.2017HIV Med 2017
Cozzi-Lepri A, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso M H, Lundgren J D, Mocroft A, Gottfredsson M, Schmid Patrick, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, EuroSIDA Study Group
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Phillips A, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J, Vernazza P, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA : the journal of the American Medical Association 2001; 286:2560-7.
28.11.2001HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
28.11.2001JAMA : the journal of the American Medical Association 2001; 286:2560-7
Phillips A N, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J D, Vernazza Pietro, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group